October 12, 2012 — An advisory committee to the Centers for Disease Control and Prevention has released recommendations on the use of 13-valent pneumococcal conjugate vaccine (PCV13; Prevnar 13, Wyeth ...

Please provide your email address to receive an email when new articles are posted on . Over the past several years, adult pneumococcal vaccine recommendations have evolved based on the development of ...

Credit: Getty Images. Findings from this survey were presented at the October 2022 ACIP meeting. While health care providers understand the value of pneumococcal vaccination, there appear to be ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and answers are republished by permission. Q: I am in my 70s and have previously ...

Vaccination rates for pneumococcal and herpes zoster vaccines are often suboptimal in veterans with chronic inflammatory diseases who are taking biologic medications. Targeted quality improvement ...

1 dose ≥8wks after last PCV dose 12 No additional vaccine 6 PCV15 or PCV20 1 dose ≥8wks after last pneumococcal vaccine 8 If PCV15 used, also give PPSV23 ≥8wks after the last PCV dose if not ...

Older adults who received the pneumococcal conjugate vaccine (PCV13) were less likely to be hospitalized for pneumonia, even if they had comorbidities that increased their risk for bad outcomes from ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. OKLAHOMA CITY (KFOR) – Anyone can get ...

Five months ago, Merck & Co. revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar 20. Now, the company is ...